7 reports

Grass Pollen Allergy - Pipeline Drugs and Companies, Q## 2019 ##.

  • Digestive System Disorder
  • Pathology

Birch Pollen Allergy - Pipeline Drugs and Companies, Q## 2019 ##.

  • Digestive System Disorder
  • Pathology
  • Therapy

The drug candidate is in Phase II stage for peanut allergy in adults and pediatrics, grass pollen allergy and dermatitis globally.

  • Antifungal
  • Diagnostic Imaging
  • Digestive System Disorder
  • Monoclonal Antibody
  • United States

The drug candidate is in Phase II stage for peanut allergy in adults and pediatrics, grass pollen allergy and dermatitis globally.

  • Antifungal
  • Diagnostic Imaging
  • Digestive System Disorder
  • United States
  • Product Initiative

The company' s product portfolio includes innovative technologies for mass spectrometry, chromatography, elemental analysis, molecular spectroscopy, cell culture analysis, allergy testing, drugs-of-abuse testing, therapeutic drug monitoring, microbiology, anatomical pa

  • Diagnostic Imaging
  • North America
  • United States
  • Forecast
  • Bruker Corporation

Drug/ Molecule refers to Primary Intervention only. ##.

  • Antifungal
  • Clinical Trial
  • Digestive System Disorder
  • Pharmaceutical
  • World

Two out of the six were considered possibly related to study drug: one in Group ## and one in Group ##.

  • Antifungal
  • Diagnostic Imaging
  • Digestive System Disorder
  • Monoclonal Antibody
  • SCYNEXIS, Inc.